Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk

Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades – JAMA Oncology (link to abstract – $ for full-text)

Commentaries: ‘Ultralow-Risk’ Breast Cancers Can Skip Endocrine Therapy – Medscape (free registration required) AND Tumor Test Helps Identify Which Breast Cancers Don’t Require Extra Treatment – NPR (free)